NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–214 of 214
From willow bark to peptides: the ever widening spectrum of NF-κB inhibitors
D’Acquisto, F., & Ianaro, A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.009 · Cited by 33
Choi, I.-K., Shin, H. J., Lee, H. S., & Kwon, H. J. (2007) · PubMed · Cited by 33
Kamer, S., Ren, Q., & Dicker, A. P. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0667-7 · Cited by 31
Ohsugi, T., Kumasaka, T., Okada, S., Ishida, T., Yamaguchi, K., Horie, R., Watanabe, T., & Umezawa, K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.07.017 · Cited by 31
Uncv (uncovered): a new mutation causing hairloss on mouse chromosome 11
LI, S.-R., WANG, D.-P., Yu, X., Ge, B., Wang, C., LU, Y.-F., LI, J.-Q., Wu, N., LI, R.-F., Zhu, S., et al. (1999) · Genetics Research · doi:10.1017/s0016672399003808 · Cited by 28
Dees, E. C., O’Neil, B. H., Lindley, C. M., Collichio, F. A., Carey, L., Collins, J., Riordan, W., Ivanova, A., Esseltine, D. L., & Orlowski, R. Z. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0716-8 · Cited by 28
Autophagy joins the game to regulate NF-κB signaling pathways
Djavaheri‐Mergny, M., & Codogno, P. (2007) · Cell Research · doi:10.1038/cr.2007.58 · Cited by 27
Kasuga, C., Ebata, T., Kayagaki, N., Yagita∥, H., Hishii, M., Aral, H., Sato, K., & Okumura, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02191.x · Cited by 27
Duechler, M., Stańczyk, M. B., Czyż, M., & Stepnik, M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0527-3 · Cited by 24
Gingras, D., Nyalendo, C., Tomasso, G. D., Annabi, B., & Béliveau, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.151 · Cited by 23
NF-κB in Pathogenesis and Treatment of Adult T-Cell Leukemia/Lymphoma
Horie, R. (2007) · International Reviews of Immunology · doi:10.1080/08830180701703364 · Cited by 23
Blocking NF-κB as a Potential Strategy to Treat Adult T-cell Leukemia/Lymphoma.
Horie, R., Watanabe, T., & Umezawa, K. (2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.4.985934 · Cited by 20
Štifter, S. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.048 · Cited by 16
Ohsugi, T., & Koito, A. (2008) · International Reviews of Immunology · doi:10.1080/08830180801939272 · Cited by 7
Cited by
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Biological activity of piceatannol: Leaving the shadow of resveratrol
Piotrowska, H., Kucinska, M., & Murias, M. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.11.001 · Cited by 476
Oxidative stress and oxidative damage in chemical carcinogenesis
Klaunig, J. E., Wang, Z., Pu, X., & Zhou, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.11.028 · Cited by 470
Metadata
- Authors
- Shen, H.-M., & Tergaonkar, V.
- Venue
- Apoptosis
- Published
- 2009-02-11
- Volume
- 14
- Issue
- 4
- Pages
- 348-363
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W2059132322
- Cited by
- 275
- References
- 214
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.